Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Cross-sectional Analysis of Insulin Sensitivity Among Adolescents and Young Adults With Type 1 Diabetes, MODY2, and Normal Controls: the Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance

NCT02971202 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02971202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02971202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Cross-sectional Analysis of Insulin Sensitivity Among Adolescents and Young Adults With Type 1 Diabetes, MODY2, and Normal Controls: the Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2016
Completion date
February 28, 2019
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, maturity-onset diabetes of the young, type 2, mody2, type 1 diabetes mellitus